favicon

IMMUNEXT

immunext.comLebanonUnited StatesBiotechnology

Company Overview

About ImmuNext

Description

ImmuNext specializes in the development of innovative immunotherapies aimed at treating autoimmune diseases and cancer. With a focus on cutting-edge research, the company strives to advance life sciences and biotechnology, offering promising therapeutic solutions for challenging medical conditions.

Specialties

Innovative immunotherapy development
Autoimmune disease treatments
Cancer immunotherapy solutions
Cutting-edge biomedical research
Life sciences advancement

Products & Services

Immunotherapies for cancer
Immunotherapies for autoimmune diseases
Research and development services
Clinical trial support
Biotechnology consulting

Contact Information

Email Addresses

Competitors & Similar Companies(8)

Sorrento Therapeutics logo

Sorrento Therapeutics

California, • United States

Bluebird Bio logo

Bluebird Bio

Massachusetts, • United States

Celyad Oncology logo

Celyad Oncology

Allogene Therapeutics logo

Allogene Therapeutics

California, • United States

Novavax logo

Novavax

Maryland, • United States

Adaptimmune logo

Adaptimmune

Pennsylvania, • United States

TCR2 Therapeutics logo

TCR2 Therapeutics

Massachusetts, • United States

Bristol Myers Squibb logo

Bristol Myers Squibb

New York, • United States

News & Media

Search Terms:
immunext
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...

Frequently Asked Questions about ImmuNext

Where is ImmuNext located?
The headquarter of ImmuNext is located in Lebanon, New Hampshire, United States
What is the email address of ImmuNext?
The email addresses of ImmuNext are [email protected]
What is the official website of ImmuNext?
The official website of ImmuNext is https://www.immunext.com
What industry does ImmuNext belong to?
ImmuNext belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of ImmuNext?
ImmuNext specializes in Innovative immunotherapy development, Autoimmune disease treatments, Cancer immunotherapy solutions, Cutting-edge biomedical research, Life sciences advancement.
What products and services is ImmuNext likely to offer?
ImmuNext offers Immunotherapies for cancer, Immunotherapies for autoimmune diseases, Research and development services, Clinical trial support, Biotechnology consulting.
Who are the competitors of ImmuNext?
Competitors of ImmuNext are Sorrento Therapeutics, Bluebird Bio, Celyad Oncology, Allogene Therapeutics, Novavax, Adaptimmune, TCR2 Therapeutics, Bristol Myers Squibb.
What does ImmuNext do?
ImmuNext specializes in the development of innovative immunotherapies aimed at treating autoimmune diseases and cancer. With a focus on cutting-edge research, the company strives to advance life sciences and biotechnology, offering promising therapeutic solutions for challenging medical conditions.
What are the social media links of ImmuNext?
Social media links of ImmuNext areLinkedIn